TAICE术后不同转归患者血清VEGF、OPN及肿瘤标志物水平分析
The level analysis of serum VEGF, OPN and tumor markers in patients with different outcomes after TAICE
-
摘要: 目的:分析经动脉免疫化疗栓塞(TAICE)术后不同转归患者血清血管内皮生长因子(VEGF)、骨保护素(OPN)及肿瘤标志物水平,明确其对术后疗效的判断意义。方法:选择中晚期肝癌患者41例,接受TAICE治疗后分别对临床疗效、VEGF及OPN、肿瘤标志物水平进行评估。结果:术后完全缓解(CR)患者4例(9.8%),部分缓解(PR)31例(75.6%),稳定(SD)4例(9.8%),进展(PD)2例(4.9%),总有效率85.4%。PR患者OPN及VEGF均明显高于CR患者(P<0.01),SD患者OPN及VEGF均较CR及PR显著升高(P<0.01),PD患者OPN及VEGF均较CR、PR及SD显著升高(P<0.01)。PR患者甲胎蛋白(AFP)、癌胚抗原(CEA)、α-L-岩藻糖苷酶(AFU)均较CR患者升高(P<0.05~P<0.01),SD患者AFP、AFU均较CR及PR显著升高(P<0.01),CEA亦较CR患者升高(P<0.05),PD患者AFP、CEA、AFU均较CR、PR及SD升高(P<0.05~P<0.01)。结论:TAICE治疗原发性肝癌具有较好的临床疗效,VEGF及OPN可作为评价其临床疗效的重要指标。Abstract: Objective:To analyze the serum levels of vascular endothelial growth factor(VEGF),osteoprotegerin(OPN) and tumor markers in patients with different outcomes after transcatheter arterial immune chemoembolization(TAICE),and its significance in evaluating postoperative effects.Methods:The clinical efficacy,and the levels of VEGF,OPN and tumor marker in 41 patients with moderate or advanced liver cancer were evaluated after TAICE.Results:The complete remission(CR) in 4 cases(9.8%),partial remission(PR) in 31 cases (75.6%),SD in 4 cases(9.8%) and PD in 2 cases(4.9%) were identified after operation,the total effective rate was 85.4%.The levels of OPN and VEGF in PR patients were significantly higher than those in CR patients(P<0.01).Compared with the CR and PR patients,the levels of OPN and VEGF in SD patients increased significantly(P<0.01).Compared with the CR,PR and SD patients,the levels of OPN and VEGF in PD patients increased significantly(P<0.01).Compared with the CR patients,the levels of AFP,CEA and AFU in PR patients increased significantly(P<0.05 to P<0.01).Compared with the CR and PR patients,the levels of AFP and AFU in SD patients increased significantly(P<0.01).Compared with the CR patients,the level of CEA in SD patients increased significantly(P<0.05).Compared with the CR,PR and SD patients,the levels of AFP,CEA and AFU in PD patients increased significantly(P<0.01).Conclusions:The treatment of hepatocellular carcinoma with TAICE has better clinical effects.The VEGF and OPN involve in development of hepatocellular carcinoma,which are the important indicators in evaluating the clinical efficacy.
-
[1] 谭文彬,周广起,王霄,等.IRE-BP 1蛋白与肝癌细胞耐药性发生机制的研究[J].国外医学(医学地理分册),2013,34(1):54. [2] TANG Q,ZHAO Y,WANG Y,et al.A genetic variant (rs17251221) in the calcium-sensing receptor relates to hepatocellular carcinoma susceptibility and clinical outcome treated by transcatheter hepatic arterial chemoembolization (TACE) therapy[J].Med Oncol,2014,31(11):267. [3] ZHANG H,GUO X,DAI J,et al.Genetic variations in IDH gene as prognosis predictors in TACE-treated hepatocellular carcinoma patients[J].Med Oncol,2014,31(11):278. [4] HUANG H,LI Y,LI C,et al.A novel anti-VEGF targeting and MRI-visible smart drug delivery system for specific diagnosis and therapy of liver cancer[J].Macromol Biosci,2013,13(10):1358. [5] LAI JP,CONLEY A,KNUDSEN BS,et al.Hypoxia after transarterial chemoembolization (TACE) may trigger a progenitor cell phenotype in hepatocellular carcinoma (HCC)[J].Histopathology,2014,10(4):288. [6] LI YP,NIU A,WEN Y.Regulation of myogenic activation of p38 MAPK by TACE-mediated TNFalpha release[J].Front Cell Dev Biol,2014,13(2):21. [7] PRAGER AJ,PENG CR,LITA E,et al.Urinary aHGF,IGFBP3 and OPN as diagnostic and prognostic biomarkers for prostate cancer[J].Biomark Med,2013,7(6):831. [8] PRAJAPATI HJ,XING M,SPIVEY JR,et al.Survival,efficacy,and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC[J].AJR,2014,203(6):W706. [9] LIU M,YANG S,ZHANG D,et al.Fructopyrano-(1-->4)-glucopyranose inhibits the proliferation of liver cancer cells and angiogenesis in a VEGF/VEGFR dependent manner[J].Int J Clin Exp Med,2014,7(11):3859. [10] CARBAJO-PESCADOR S,ORDONEZ R,BENET M,et al.Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells[J].Br J Cancer,2013,109(1):83. [11] SHENG XJ,ZHOU DM,LIU Q,et al.BRMS1 inhibits expression of NF-κB subunit p65,uPA and OPN in ovarian cancer cells[J].Eur J Gynaecol Oncol,2014,35(3):236. [12] LIU H,LI P,LI B,et al.RKIP inhibits gastric cancer cell survival and invasion by regulating the expression of HMGA2 and OPN[J].Tumour Biol,2014,35(12):11949. -
点击查看大图
计量
- 文章访问数: 3937
- HTML全文浏览量: 547
- PDF下载量: 113
- 被引次数: 0
下载:
